State and trait of finger tapping performance in multiple sclerosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 08 2021
Historique:
received: 19 02 2021
accepted: 20 07 2021
entrez: 25 8 2021
pubmed: 26 8 2021
medline: 3 11 2021
Statut: epublish

Résumé

Finger tapping tests have been shown feasible to assess motor performance in multiple sclerosis (MS) and were observed to be strongly associated with the estimated clinical severity of the disease. Therefore, tapping tests could be an adequate tool to assess disease status in MS. In this study we examined potential influencing factors on a maximum tapping task with the whole upper-limb for 10 s in 40 MS patients using linear mixed effects modelling. Patients were tested in three sessions with two trials per body-side per session over the course of 4-27 days of inpatient rehabilitation. Tested factors were the expanded disability scale (EDSS) score, laterality of MS, age, sex, hand dominance, time of day, session, trial (first or second), time between sessions, and the reported day form. A second model used these factors to examine the self-reported day form of patients. Linear mixed effects modelling indicated the tapping test to have a good inter-trial (proportional variance < 0.01) and inter-session reliability (non-significant; when controlling for time between sessions), an influence of hand-dominance (proportional variance 0.08), to be strongly associated with the EDSS (eta

Identifiants

pubmed: 34429445
doi: 10.1038/s41598-021-96485-3
pii: 10.1038/s41598-021-96485-3
pmc: PMC8384844
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17095

Informations de copyright

© 2021. The Author(s).

Références

Neurorehabil Neural Repair. 2015 Sep;29(8):796-802
pubmed: 25605633
Percept Mot Skills. 2002 Dec;95(3 Pt 1):965-72
pubmed: 12509204
Exp Brain Res. 2006 Sep;174(2):199-209
pubmed: 16604315
Adv Exp Med Biol. 2017;958:141-159
pubmed: 28093712
Mult Scler Relat Disord. 2019 Jul;32:107-113
pubmed: 31085489
J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):361-5
pubmed: 11861697
Neurorehabil Neural Repair. 2017 May;31(5):413-431
pubmed: 28413944
Neurol Sci. 2001 Apr;22(2):117-39
pubmed: 11603614
Indian J Physiol Pharmacol. 1999 Oct;43(4):458-62
pubmed: 10776461
Schizophr Res. 2000 Sep 29;45(1-2):157-67
pubmed: 10978883
Percept Mot Skills. 1986 Apr;62(2):675-8
pubmed: 3503282
Exp Brain Res. 2019 Jun;237(6):1383-1395
pubmed: 30887078
J Appl Physiol (1985). 2010 Nov;109(5):1531-7
pubmed: 20671034
BMC Neurol. 2017 Mar 21;17(1):55
pubmed: 28327094
J Behav Med. 2017 Oct;40(5):772-783
pubmed: 28281106
Acta Neurol Belg. 2016 Dec;116(4):481-487
pubmed: 27037821
Mult Scler Relat Disord. 2021 Feb;48:102674
pubmed: 33340928
Evol Med Public Health. 2018 Jan 23;2018(1):43-59
pubmed: 29492266
Int J MS Care. 2013 Fall;15(3):146-58
pubmed: 24453777
J Neurol. 2018 Feb;265(2):285-290
pubmed: 29204963
Arch Phys Med Rehabil. 2006 Jan;87(1):40-4
pubmed: 16401436
Mult Scler Relat Disord. 2018 Jan;19:1-5
pubmed: 29158119
Mult Scler J Exp Transl Clin. 2017 Jan 01;3(1):2055217316688930
pubmed: 28680701
Eur J Appl Physiol. 2014 Sep;114(9):1841-51
pubmed: 24878689
Mult Scler. 2008 Aug;14(7):988-91
pubmed: 18505775
Percept Mot Skills. 2013 Jun;116(3):929-52
pubmed: 24175464
Percept Mot Skills. 1993 Jun;76(3 Pt 2):1219-30
pubmed: 8337069
Chronobiol Int. 2002 Nov;19(6):1137-49
pubmed: 12511031
Exerc Sport Sci Rev. 2016 Oct;44(4):123-8
pubmed: 27465682
Curr Neurol Neurosci Rep. 2018 Jan 29;18(1):2
pubmed: 29380072
Int J Neurosci. 1995 Nov;83(1-2):1-6
pubmed: 8746744

Auteurs

Philipp Gulde (P)

Centre for Clinical Neuroplasticity, Medical Park Loipl (Medical Park Group), Thanngasse 15, 83483, Bischofswiesen, Germany. p.gulde@medicalpark.de.
Technical University of Munich, Munich, Germany. p.gulde@medicalpark.de.

Heike Vojta (H)

Centre for Clinical Neuroplasticity, Medical Park Loipl (Medical Park Group), Thanngasse 15, 83483, Bischofswiesen, Germany.

Joachim Hermsdörfer (J)

Technical University of Munich, Munich, Germany.

Peter Rieckmann (P)

Centre for Clinical Neuroplasticity, Medical Park Loipl (Medical Park Group), Thanngasse 15, 83483, Bischofswiesen, Germany.
Friedich-Alexander University Erlangen-Nurnberg, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH